Systematic review: chronic viral hepatitis and metabolic derangement
CC Wang, PN Cheng, JH Kao - Alimentary pharmacology & …, 2020 - Wiley Online Library
Background The liver has a critical role in the metabolism of glucose and lipids. Chronic
hepatitis B virus (HBV) or hepatitis C virus (HCV) infection leads to a spectrum of liver …
hepatitis B virus (HBV) or hepatitis C virus (HCV) infection leads to a spectrum of liver …
[HTML][HTML] Metabolic complications of hepatitis C virus infection
R Chaudhari, S Fouda, A Sainu… - World journal of …, 2021 - ncbi.nlm.nih.gov
Hepatitis C virus (HCV) infection is a systemic disease that is implicated in multiple
extrahepatic organ dysfunction contributing to its protean manifestations. HCV is associated …
extrahepatic organ dysfunction contributing to its protean manifestations. HCV is associated …
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease: A decalogue from the Italian Association for the Study of the Liver (AISF) …
P Loria, LE Adinolfi, S Bellentani, E Bugianesi… - Digestive and Liver …, 2010 - Elsevier
We report the evidence-based Italian Association for the Study of Liver guidelines for the
appropriate diagnosis and management of patients with nonalcoholic fatty liver disease in …
appropriate diagnosis and management of patients with nonalcoholic fatty liver disease in …
[PDF][PDF] Hepatitis C genotype 4: What we know and what we don't yet know
SM Kamal, IA Nasser - Hepatology, 2008 - Wiley Online Library
Hepatitis C virus genotype 4 (HCV‐4) is the most common variant of the hepatitis C virus
(HCV) in the Middle East and Africa, particularly Egypt. This region has the highest …
(HCV) in the Middle East and Africa, particularly Egypt. This region has the highest …
[HTML][HTML] Metabolic alterations and hepatitis C: From bench to bedside
ML Chang - World journal of gastroenterology, 2016 - ncbi.nlm.nih.gov
In addition to causing cirrhosis and hepatocellular carcinoma, hepatitis C virus (HCV) is
thought to cause hypolipidemia, hepatic steatosis, insulin resistance, metabolic syndrome …
thought to cause hypolipidemia, hepatic steatosis, insulin resistance, metabolic syndrome …
[HTML][HTML] Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review
AC Desbois, P Cacoub - World journal of gastroenterology, 2017 - ncbi.nlm.nih.gov
AIM To summarise the literature data on hepatitis C virus (HCV)-infected patients concerning
the prevalence of glucose abnormalities and associated risk. METHODS We conducted a …
the prevalence of glucose abnormalities and associated risk. METHODS We conducted a …
[HTML][HTML] Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV
A Lonardo, S Ballestri, G Guaraldi… - World journal of …, 2016 - ncbi.nlm.nih.gov
Fatty liver, which frequently coexists with necro-inflammatory and fibrotic changes, may
occur in the setting of nonalcoholic fatty liver disease (NAFLD) and chronic infections due to …
occur in the setting of nonalcoholic fatty liver disease (NAFLD) and chronic infections due to …
Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort
SA Pergam, CC Wang, CM Gardella… - American journal of …, 2008 - Elsevier
OBJECTIVE: The objective of the study was to determine the effect of hepatitis C virus (HCV)
on selected maternal and infant birth outcomes. STUDY DESIGN: This population-based …
on selected maternal and infant birth outcomes. STUDY DESIGN: This population-based …
Risk factors for fatty liver in the Multicenter AIDS Cohort Study
JC Price, EC Seaberg, R Latanich… - Official journal of the …, 2014 - journals.lww.com
OBJECTIVES: Human immunodeficiency virus (HIV) infection and antiretroviral therapy
(ART) may increase the risk of fatty liver disease. We determined the prevalence of and risk …
(ART) may increase the risk of fatty liver disease. We determined the prevalence of and risk …
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology
Background Liver regulates lipid metabolism in health and disease states. Nevertheless, the
entity of cardiovascular risk (CVR) resulting from dysregulation of lipid metabolism …
entity of cardiovascular risk (CVR) resulting from dysregulation of lipid metabolism …